Predicting the response to neoadjuvant chemotherapy in gastric cancer / 国际外科学杂志
International Journal of Surgery
;
(12): 701-705, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-478345
ABSTRACT
Randomized trials have demonstrated a benefit from neoadjuvant chemotherapy in gastric cancer.However the optimal approach in individual patients is not clear.There are differences in the chemical drug sensitivities of individual patients.This scenario demands the development of methods to predict response to neoadjuvant therapy.This paper reviews the relevant research progress.Published results are as followshistological characteristics and histopathological response corelate with survival,traditional imaging needs improvement and integration to increase the accuracy,while PET holds advantage in early selection of patients without response,and existing candidate biomarkers need to bc properly qualified.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
/
Estudio pronóstico
Idioma:
Chino
Revista:
International Journal of Surgery
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS